Total Payments
$2,955
2024 Payments
$64.01
Companies
26
Transactions
105
Medicare Patients
1,996
Medicare Billing
$212,814
Payment Breakdown by Category
Food & Beverage$1,645 (55.7%)
Travel$968.87 (32.8%)
Other$157.38 (5.3%)
Gifts$150.05 (5.1%)
Education$34.00 (1.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,645 | 93 | 55.7% |
| Travel and Lodging | $968.87 | 3 | 32.8% |
| Gift | $150.05 | 2 | 5.1% |
| Long term medical supply or device loan | $90.64 | 4 | 3.1% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $66.74 | 1 | 2.3% |
| Education | $34.00 | 2 | 1.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Apollo Endosurgery US Inc | $1,110 | 7 | $0 (2017) |
| ABBVIE INC. | $499.66 | 36 | $0 (2024) |
| FUJIFILM Medical Systems USA, Inc. | $216.79 | 3 | $0 (2020) |
| BOSTON SCIENTIFIC CORPORATION | $177.12 | 2 | $0 (2017) |
| Janssen Scientific Affairs, LLC | $112.01 | 2 | $0 (2017) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $91.53 | 6 | $0 (2019) |
| FUJIFILM Healthcare Americas Corporation | $90.64 | 4 | $0 (2022) |
| Celgene Corporation | $78.08 | 5 | $0 (2023) |
| QOL Medical, LLC | $69.15 | 5 | $0 (2019) |
| Gilead Sciences, Inc. | $64.59 | 5 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $64.01 | 3 | Lilly USA, LLC ($32.85) |
| 2023 | $106.94 | 6 | Celgene Corporation ($49.00) |
| 2022 | $144.51 | 9 | ABBVIE INC. ($61.07) |
| 2021 | $84.28 | 4 | FUJIFILM Healthcare Americas Corporation ($63.62) |
| 2020 | $170.99 | 3 | FUJIFILM Medical Systems USA, Inc. ($150.05) |
| 2019 | $103.61 | 7 | QOL Medical, LLC ($69.15) |
| 2018 | $409.55 | 27 | AbbVie, Inc. ($160.24) |
| 2017 | $1,872 | 46 | Apollo Endosurgery US Inc ($1,110) |
All Payment Transactions
105 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/29/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $32.85 | General |
| Category: Immunology | ||||||
| 07/16/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $13.81 | General |
| Category: INTERNAL MEDICINE | ||||||
| 04/03/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ, HUMIRA | Food and Beverage | In-kind items and services | $17.35 | General |
| Category: IMMUNOLOGY | ||||||
| 10/12/2023 | Celltrion USA Inc. | YUFLYMA (Biological) | Education | In-kind items and services | $19.50 | General |
| Category: IMMUNOLOGY | ||||||
| 06/23/2023 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $18.48 | General |
| Category: Neuroscience | ||||||
| 06/13/2023 | AbbVie Inc. | CREON (Drug), LINZESS, VIBERZI | Food and Beverage | In-kind items and services | $22.65 | General |
| Category: ENDOCRINOLOGY | ||||||
| 06/10/2023 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $16.96 | General |
| Category: Neuroscience | ||||||
| 03/03/2023 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $13.56 | General |
| Category: Neuroscience | ||||||
| 01/25/2023 | Ironwood Pharmaceuticals, Inc | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $15.79 | General |
| Category: GI | ||||||
| 12/15/2022 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $13.86 | General |
| Category: VIROLOGY | ||||||
| 12/13/2022 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $16.13 | General |
| Category: Neuroscience | ||||||
| 11/08/2022 | INTRA-SANA LABORATORIES | RELTONE 200 MG (Drug), RELTONE 400 MG | Food and Beverage | In-kind items and services | $12.87 | General |
| Category: Gallstones | ||||||
| 09/23/2022 | ABBVIE INC. | LINZESS (Drug), CREON, VIBERZI | Food and Beverage | In-kind items and services | $14.65 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/09/2022 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $12.95 | General |
| Category: Neuroscience | ||||||
| 09/06/2022 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $18.38 | General |
| Category: VIROLOGY | ||||||
| 08/02/2022 | PFIZER INC. | XELJANZ (Drug), PAXLOVID | Food and Beverage | In-kind items and services | $14.47 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 08/01/2022 | FUJIFILM Healthcare Americas Corporation | FUJIFILM (Device) | Long term medical supply or device loan | In-kind items and services | $27.02 | General |
| Category: Medical Device | ||||||
| 07/01/2022 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $14.18 | General |
| Category: VIROLOGY | ||||||
| 06/04/2021 | FUJIFILM Healthcare Americas Corporation | FUJIFILM (Device) | Long term medical supply or device loan | In-kind items and services | $26.05 | General |
| Category: Medical Device | ||||||
| 05/20/2021 | FUJIFILM Healthcare Americas Corporation | FUJIFILM (Device) | Long term medical supply or device loan | In-kind items and services | $16.58 | General |
| Category: Medical Device | ||||||
| 03/29/2021 | FUJIFILM Healthcare Americas Corporation | FUJIFILM (Device) | Long term medical supply or device loan | In-kind items and services | $20.99 | General |
| Category: Medical Device | ||||||
| 01/04/2021 | AbbVie Inc. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $20.66 | General |
| Category: VIROLOGY | ||||||
| 11/20/2020 | FUJIFILM Medical Systems USA, Inc. | ESD - Core Endoscopy (Device) | Gift | In-kind items and services | $1.82 | General |
| Category: Medical Device | ||||||
| 04/09/2020 | FUJIFILM Medical Systems USA, Inc. | ESD - Core Endoscopy (Device) | Gift | In-kind items and services | $148.23 | General |
| Category: Medical Device | ||||||
| 02/11/2020 | AbbVie Inc. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $20.94 | General |
| Category: VIROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 443 | 457 | $252,930 | $44,646 |
| 2022 | 12 | 517 | 535 | $291,485 | $55,800 |
| 2021 | 15 | 561 | 588 | $328,605 | $63,223 |
| 2020 | 11 | 475 | 511 | $249,187 | $49,145 |
Total Patients
1,996
Total Services
2,091
Medicare Billing
$212,814
Procedure Codes
51
All Medicare Procedures & Services
51 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 81 | 81 | $93,960 | $15,463 | 16.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 67 | 69 | $17,940 | $6,037 | 33.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 64 | 69 | $12,420 | $4,060 | 32.7% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 48 | 48 | $36,970 | $3,732 | 10.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 24 | 24 | $8,640 | $2,604 | 30.1% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 13 | 13 | $11,310 | $2,152 | 19.0% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 23 | 23 | $6,900 | $2,133 | 30.9% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 26 | 27 | $17,820 | $1,878 | 10.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 26 | 26 | $6,500 | $1,872 | 28.8% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 13 | 13 | $11,310 | $1,719 | 15.2% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 17 | 17 | $17,510 | $1,484 | 8.5% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 18 | 21 | $2,100 | $790.65 | 37.7% |
| 43450 | Dilation of esophagus | Facility | 2023 | 23 | 26 | $9,550 | $721.08 | 7.6% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 80 | 81 | $94,400 | $15,051 | 15.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 76 | 88 | $18,260 | $7,928 | 43.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 68 | 68 | $20,905 | $7,799 | 37.3% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 71 | 73 | $55,480 | $6,481 | 11.7% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 24 | 24 | $9,120 | $3,696 | 40.5% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 37 | 37 | $38,110 | $3,597 | 9.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 42 | 43 | $6,060 | $2,798 | 46.2% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 15 | 15 | $13,050 | $2,696 | 20.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 31 | 31 | $6,300 | $2,313 | 36.7% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 25 | 25 | $17,040 | $1,938 | 11.4% |
| 43450 | Dilation of esophagus | Facility | 2022 | 33 | 34 | $11,560 | $1,048 | 9.1% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 15 | 16 | $1,200 | $454.35 | 37.9% |
About Dr. Blake Scott, M.D
Dr. Blake Scott, M.D is a Internal Medicine healthcare provider based in Winston Salem, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/07/2009. The National Provider Identifier (NPI) number assigned to this provider is 1962645929.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Blake Scott, M.D has received a total of $2,955 in payments from pharmaceutical and medical device companies, with $64.01 received in 2024. These payments were reported across 105 transactions from 26 companies. The most common payment nature is "Food and Beverage" ($1,645).
As a Medicare-enrolled provider, Scott has provided services to 1,996 Medicare beneficiaries, totaling 2,091 services with total Medicare billing of $212,814. Data is available for 4 years (2020–2023), covering 51 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Gastroenterology
- Location Winston Salem, NC
- Active Since 04/07/2009
- Last Updated 11/27/2023
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1962645929
Products in Payments
- Orbera (Device) $740.90
- ORBERA (Device) $368.85
- ESD - Core Endoscopy (Device) $216.79
- STELARA (Biological) $159.36
- Mavyret (Drug) $149.14
- Humira (Biological) $108.66
- FUJIFILM (Device) $90.64
- GENERAL - BIOPSY (Device) $88.83
- ADVANIX BILIARY STENT (Device) $88.29
- MAVYRET (Drug) $88.02
- ZEPOSIA (Drug) $78.08
- Viekira (Drug) $74.06
- Sucraid (Drug) $69.15
- XIFAXAN (Drug) $65.71
- XIFAXANIBSD (Drug) $54.91
- Entyvio (Biological) $34.49
- OMVOH (Drug) $32.85
- UCERIS TABLETS (Drug) $27.38
- VPRIV (Biological) $27.30
- OCA (Drug) $26.65
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Winston Salem
Dr. Hassan Alhosaini, M.d, M.D
Internal Medicine — Payments: $322,339
Internal Medicine $322,339
Jamy Ard, Md, MD
Internal Medicine — Payments: $272,273
Internal Medicine $272,273
Dr. Katharine Batt, M.d., Msc, M.D., MSC
Internal Medicine — Payments: $207,180
Internal Medicine $207,180
Mr. James Dugan, Md, MD
Internal Medicine — Payments: $165,584
Internal Medicine $165,584
Suman Wasan, Md, MD
Internal Medicine — Payments: $89,012
Internal Medicine $89,012
Dr. Mahesh Chandrasekhar, M.d, M.D
Internal Medicine — Payments: $59,424
Internal Medicine $59,424